4th Circ. Sides With CMS' Definition Of 'Line-Extension Drug'

The Fourth Circuit on Wednesday affirmed a summary judgment ruling in favor of the Centers for Medicare & Medicaid Services in a rule challenge by Vanda Pharmaceuticals, which took issue with...